NEW Product: MagBeads FastDNA™ Kit for Feces request your FREE sample
Product Description
Thalidomide
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Inhibitor of HIV-1 replication
Specifications
SKU | 02158753-CF |
Alternate Names | (±)-N-(2,6-Dioxo-3-piperidinyl)phthalimide; (±)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione; (±)-Thalidomide |
Base Catalog Number | 158753 |
Biochemical Physiological Actions | (±)-Thalidomide selectively inhibits biosynthesis of tumor necrosis factor α (TNF-α); inhibitor of angiogenesis; immunosuppressive; sedative; teratogen. |
CAS # | 50-35-1 |
EC Number | 200-031-1 |
Format | Powder |
Hazard Statements | H301-H312-H361 |
Melting Point | 516 to 520° F (NTP, 1992) |
Molecular Formula | C13H10N2O4 |
Molecular Weight | 258.233 g/mol |
Personal Protective Equipment | Eyeshields, Faceshields, full-face particle respirator , Gloves, respirator cartridge, respirator filter |
Purity | ≥99% |
RTECS Number | TI4375000 |
Safety Symbol | GHS06, GHS08 |
Solubility | less than 1 mg/mL at 72° F (NTP, 1992) |
Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |
Vapor Pressure | 2.05X10-14 mm Hg at 25 deg C (est) |
Documents
Certificate of Analysis (COA)
Datasheet
Datasheet
Safety Data Sheets
English (United States)